tiprankstipranks
Advertisement
Advertisement

PLX Stock Latest News

Protalix Shareholders Approve Directors, Compensation and Incentive Plan
Company AnnouncementsProtalix Shareholders Approve Directors, Compensation and Incentive Plan
13d ago
8K
PLX
Ram Selvaraju Reiterates Buy on Protalix, Maintains $12 Price Target on Elfabrio Momentum and Pipeline Upside
PremiumRatings
Ram Selvaraju Reiterates Buy on Protalix, Maintains $12 Price Target on Elfabrio Momentum and Pipeline Upside
1M ago
PLX
Protalix Highlights Elfabrio Dosing Approvals and Growth Plans
PremiumCompany Announcements
Protalix Highlights Elfabrio Dosing Approvals and Growth Plans
2M ago
8K
PLX
Protalix Q1 Call: Milestone-Fueled Profit, Bold Targets
PremiumCompany Announcements
Protalix Q1 Call: Milestone-Fueled Profit, Bold Targets
2M ago
PLX
PLX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PLX Upcoming Earnings Report: What to Expect?
2M ago
PLX
Protalix Earnings Call: EU Win, Cash Boost, Trade-Offs
PremiumCompany AnnouncementsProtalix Earnings Call: EU Win, Cash Boost, Trade-Offs
3M ago
PLX
Protalix: EU Approval and Commercial Tailwinds for Elfabrio Underscore Undervalued Upside
Premium
Ratings
Protalix: EU Approval and Commercial Tailwinds for Elfabrio Underscore Undervalued Upside
4M ago
PLX
PLX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PLX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
PLX
Protalix Gains EU Approval for Extended Elfabrio Dosing
PremiumCompany Announcements
Protalix Gains EU Approval for Extended Elfabrio Dosing
4M ago
8K
PLX
Protalix, Chiesi Global Rare Diseases: EC approves dosing regimen for Elfabrio
PremiumThe Fly
Protalix, Chiesi Global Rare Diseases: EC approves dosing regimen for Elfabrio
4M ago
PLX
Protalix Advances RELEASE Gout Trial, Sharpening Its Long Term Biotech Upside
PremiumCompany Announcements
Protalix Advances RELEASE Gout Trial, Sharpening Its Long Term Biotech Upside
4M ago
PLX
Protalix Highlights Positive EMA Opinion on Elfabrio Dosing
PremiumCompany Announcements
Protalix Highlights Positive EMA Opinion on Elfabrio Dosing
5M ago
8K
PLX
Protalix Wins EMA Panel Backing for New Elfabrio Dosing
PremiumCompany AnnouncementsProtalix Wins EMA Panel Backing for New Elfabrio Dosing
5M ago
8K
PLX
Protalix, Chiesi Global: CHMP issues positive opinion for Elfabrio dosing
Premium
The Fly
Protalix, Chiesi Global: CHMP issues positive opinion for Elfabrio dosing
5M ago
PLX
Protalix outlines 2026 rare-disease growth and pipeline strategy
Premium
Company Announcements
Protalix outlines 2026 rare-disease growth and pipeline strategy
6M ago
8K
PLX
Protalix: Pipeline Expansion and Elfabrio Growth Drive Attractive Risk‑Reward and Undervalued Buy Rating
PremiumRatings
Protalix: Pipeline Expansion and Elfabrio Growth Drive Attractive Risk‑Reward and Undervalued Buy Rating
7M ago
PLX
Protalix, Secarna Pharmaceuticals enter collaboration and option agreement
PremiumThe Fly
Protalix, Secarna Pharmaceuticals enter collaboration and option agreement
7M ago
PLX
Protalix price target lowered to $12 from $15 at H.C. Wainwright
PremiumThe Fly
Protalix price target lowered to $12 from $15 at H.C. Wainwright
8M ago
PLX
Protalix BioTherapeutics Reports Strong Revenue Growth in 2025
PremiumCompany Announcements
Protalix BioTherapeutics Reports Strong Revenue Growth in 2025
8M ago
PLX
Protalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges
PremiumCompany AnnouncementsProtalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges
8M ago
PLX
Protalix reports Q3 EPS 3c, consensus 5c
Premium
The Fly
Protalix reports Q3 EPS 3c, consensus 5c
8M ago
PLX
PLX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PLX Upcoming Earnings Report: What to Expect?
8M ago
PLX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >